{"id":"calcipotriol","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Adrenal cortical hypofunction","Atrophoderma","Congenital ichthyosis of skin","Disorder of calcium metabolism","Guttate psoriasis","Hypercalcemia","Hypercalciuria","Hypervitaminosis D","Peripheral vascular disease","Pustular psoriasis","Telangiectasia disorder"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":{"chemblId":"CHEMBL4563773","moleculeType":"Unknown","molecularWeight":"412.61"},"aliases":["Dovonex Cream (50 mcg/g 0.005%)","Platelet Rich Plasma","Dovonex","Calcipotriol 0.005%","calcipoheal"],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=calcipotriol","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:22:21.622045+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:22:26.877150+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=calcipotriol","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:22:27.223235+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4563773/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:22:27.935913+00:00"}},"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Vitamin D3 receptor"},"_scrapedAt":"2026-03-27T23:43:06.467Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:22:29.596478+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Plaque psoriasis","diseaseId":"plaque-psoriasis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Scalp psoriasis","diseaseId":"scalp-psoriasis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07453472","phase":"PHASE3","title":"Comparison of Topical Photodynamic Therapy With Topical Calcipotriol in Management of Oral Leukoplakia","status":"NOT_YET_RECRUITING","sponsor":"Dr. Shalini Gupta","startDate":"2026-04","conditions":"Oral Leukoplakia","enrollment":166},{"nctId":"NCT07453238","phase":"PHASE4","title":"Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia Areata","status":"NOT_YET_RECRUITING","sponsor":"Hayat Abad Medical Complex, Peshawar","startDate":"2026-04-01","conditions":"Alopecia Areata","enrollment":60},{"nctId":"NCT07410793","phase":"PHASE2","title":"Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis.","status":"RECRUITING","sponsor":"Mae Fah Luang University","startDate":"2026-02-09","conditions":"Plaque Type Psorisis","enrollment":28},{"nctId":"NCT07401992","phase":"PHASE4","title":"Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis","status":"RECRUITING","sponsor":"Hospital Universitario Dr. Jose E. Gonzalez","startDate":"2026-01-15","conditions":"Psoriasis (PsO), Obesity & Overweight, Diabetes Mellitus - Type 2","enrollment":62},{"nctId":"NCT07357831","phase":"PHASE3","title":"A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects","status":"RECRUITING","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2025-12-26","conditions":"Plaque Psoriasis","enrollment":537},{"nctId":"NCT07352566","phase":"PHASE4","title":"Utilization of a Microdevice for Psoriasis and Atopic Dermatitis","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-01-01","conditions":"Psoriasis, Atopic Dermatitis","enrollment":10},{"nctId":"NCT06737406","phase":"NA","title":"Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart","status":"RECRUITING","sponsor":"Mazandaran University of Medical Sciences","startDate":"2025-05-30","conditions":"Common Warts","enrollment":60},{"nctId":"NCT05381597","phase":"PHASE2, PHASE3","title":"5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer","status":"RECRUITING","sponsor":"Boston University","startDate":"2022-10-15","conditions":"Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ","enrollment":200},{"nctId":"NCT06851507","phase":"PHASE3","title":"A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene Field Treatments in Patients With Multiple Actinic Keratoses","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-10-06","conditions":"Multiple Actinic Keratoses","enrollment":30},{"nctId":"NCT05185258","phase":"PHASE4","title":"Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2022-02-16","conditions":"Psoriasis Vulgaris, Psoriasis, Skin Diseases","enrollment":12},{"nctId":"NCT05699603","phase":"PHASE2","title":"Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Arizona","startDate":"2024-07-02","conditions":"Actinic Keratosis","enrollment":56},{"nctId":"NCT05811234","phase":"","title":"A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults","status":"COMPLETED","sponsor":"Almirall, S.A.","startDate":"2023-06-13","conditions":"Plaque Psoriasis","enrollment":291},{"nctId":"NCT06880042","phase":"EARLY_PHASE1","title":"COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO","status":"ENROLLING_BY_INVITATION","sponsor":"Dr ayesha wahid","startDate":"2025-05-01","conditions":"Vitiligo - Macular Depigmentation, Tacrolimus","enrollment":60},{"nctId":"NCT03370406","phase":"PHASE1","title":"Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC","status":"RECRUITING","sponsor":"Melissa Pugliano-Mauro","startDate":"2018-08-03","conditions":"Carcinoma, Squamous Cell","enrollment":30},{"nctId":"NCT06499415","phase":"PHASE4","title":"Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis","status":"RECRUITING","sponsor":"Maastricht University Medical Center","startDate":"2024-09-04","conditions":"Actinic Keratoses","enrollment":232},{"nctId":"NCT03596073","phase":"PHASE1","title":"Topical Calcipotriene Treatment for Breast Cancer Immunoprevention","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2018-11-07","conditions":"Breast Cancer","enrollment":43},{"nctId":"NCT04329221","phase":"PHASE2","title":"Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2026-01-01","conditions":"Cutaneous Squamous Cell Carcinoma, Actinic Keratoses, Skin Cancer","enrollment":""},{"nctId":"NCT04642287","phase":"PHASE2","title":"Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2026-01","conditions":"Immunotherapy, Cutaneous Squamous Cell Carcinoma, Actinic Keratoses","enrollment":""},{"nctId":"NCT01195831","phase":"PHASE3","title":"Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-09","conditions":"Scalp Psoriasis","enrollment":244},{"nctId":"NCT00875277","phase":"PHASE2","title":"A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2009-04","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT01422434","phase":"PHASE3","title":"LEO 90105 Ointment in Japanese Subjects With Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2011-07","conditions":"Psoriasis","enrollment":676},{"nctId":"NCT00817219","phase":"PHASE2","title":"Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2009-07","conditions":"Psoriasis Vulgaris","enrollment":33},{"nctId":"NCT01580488","phase":"PHASE1","title":"A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2012-04","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT01768013","phase":"PHASE1, PHASE2","title":"The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2012-07","conditions":"Psoriasis Vulgaris","enrollment":13},{"nctId":"NCT01120223","phase":"PHASE2","title":"Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-05","conditions":"Scalp Psoriasis","enrollment":78},{"nctId":"NCT01083758","phase":"PHASE2","title":"Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-04","conditions":"Scalp Psoriasis","enrollment":31},{"nctId":"NCT02038569","phase":"PHASE2","title":"An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2014-01","conditions":"Psoriasis Vulgaris","enrollment":125},{"nctId":"NCT03806790","phase":"PHASE3","title":"Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2019-01-24","conditions":"Psoriasis Vulgaris","enrollment":182},{"nctId":"NCT01866163","phase":"PHASE3","title":"LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2013-06","conditions":"Psoriasis Vulgaris","enrollment":426},{"nctId":"NCT01188928","phase":"PHASE3","title":"LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-09","conditions":"Psoriasis Vulgaris","enrollment":1152},{"nctId":"NCT02132936","phase":"PHASE3","title":"LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2014-06","conditions":"Psoriasis Vulgaris","enrollment":504},{"nctId":"NCT00691002","phase":"PHASE3","title":"Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Folds","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2008-05","conditions":"Psoriasis Vulgaris","enrollment":1245},{"nctId":"NCT02310646","phase":"PHASE3","title":"Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-01","conditions":"Psoriasis Vulgaris","enrollment":219},{"nctId":"NCT00670241","phase":"PHASE3","title":"Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2008-04","conditions":"Psoriasis Vulgaris","enrollment":458},{"nctId":"NCT02668692","phase":"PHASE3","title":"LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2016-02","conditions":"Psoriasis Vulgaris","enrollment":213},{"nctId":"NCT02518048","phase":"PHASE2","title":"A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-08","conditions":"Skin and Connective Tissue Diseases","enrollment":35},{"nctId":"NCT01600222","phase":"PHASE2","title":"Effect of LEO 90100 on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis VulgarisExtensive Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2012-05","conditions":"Psoriasis Vulgaris","enrollment":37},{"nctId":"NCT01536886","phase":"PHASE2","title":"LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2012-05","conditions":"Psoriasis Vulgaris","enrollment":376},{"nctId":"NCT01536938","phase":"PHASE2","title":"LEO 90100 in the Treatment of Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2012-05","conditions":"Psoriasis Vulgaris","enrollment":303},{"nctId":"NCT00764751","phase":"PHASE2","title":"Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2008-09","conditions":"Psoriasis Vulgaris","enrollment":51},{"nctId":"NCT00640822","phase":"PHASE3","title":"Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2008-02","conditions":"Psoriasis Vulgaris","enrollment":782},{"nctId":"NCT01007591","phase":"PHASE3","title":"A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and Intertriginous Areas","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2009-10","conditions":"Psoriasis Vulgaris","enrollment":40},{"nctId":"NCT01347255","phase":"PHASE2","title":"A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2011-05","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT00704262","phase":"PHASE2","title":"Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2008-05","conditions":"Psoriasis Vulgaris","enrollment":33},{"nctId":"NCT01105286","phase":"PHASE1","title":"A Psoriasis Plaque Test Comparing Eight Different Formulations of Vitamin D Analogues for the Treatment of Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-04","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT00392067","phase":"PHASE2","title":"LEO19123 Cream in the Treatment of Atopic Dermatitis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2006-10","conditions":"Atopic Dermatitis","enrollment":75},{"nctId":"NCT02533973","phase":"PHASE4","title":"Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-09","conditions":"Psoriasis Vulgaris","enrollment":951},{"nctId":"NCT01837576","phase":"PHASE1","title":"An Exploratory Psoriasis Plaque Test Study With Different Dose Combinations of Calcipotriol Plus Betamethasone Dipropionate in the Daivobet® Gel Vehicle in Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2013-04","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT00216892","phase":"PHASE4","title":"Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2005-04","conditions":"Psoriasis Vulgaris","enrollment":1032},{"nctId":"NCT01052467","phase":"","title":"Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-01","conditions":"Scalp Psoriasis","enrollment":724},{"nctId":"NCT03898583","phase":"PHASE1","title":"Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2019-04-15","conditions":"Psoriasis Vulgaris","enrollment":15},{"nctId":"NCT01043224","phase":"PHASE1","title":"A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-01","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT00243464","phase":"PHASE3","title":"Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2005-09","conditions":"Psoriasis of Scalp","enrollment":300},{"nctId":"NCT02416258","phase":"PHASE2","title":"A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-04","conditions":"Skin and Connective Tissue Diseases","enrollment":50},{"nctId":"NCT01297166","phase":"PHASE1","title":"A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2011-02","conditions":"Psoriasis Vulgaris","enrollment":25},{"nctId":"NCT00216827","phase":"PHASE3","title":"Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2004-11","conditions":"Psoriasis of Scalp","enrollment":1485},{"nctId":"NCT03442244","phase":"PHASE1","title":"Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2018-01-30","conditions":"Psoriasis Vulgaris","enrollment":20},{"nctId":"NCT00216879","phase":"PHASE3","title":"Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2005-02","conditions":"Psoriasis of Scalp","enrollment":800},{"nctId":"NCT01105234","phase":"PHASE1","title":"An Irritation Study With New Calcipotriol Ointment Formulations in Healthy Subjects","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-04","conditions":"Irritation","enrollment":24},{"nctId":"NCT01229098","phase":"PHASE2","title":"Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-10","conditions":"Psoriasis Vulgaris","enrollment":102},{"nctId":"NCT00248456","phase":"PHASE4","title":"Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2005-10","conditions":"Psoriasis Vulgaris","enrollment":320},{"nctId":"NCT01466478","phase":"PHASE1","title":"An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2011-11","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT00263718","phase":"PHASE2","title":"Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2005-12","conditions":"Psoriasis Vulgaris","enrollment":360},{"nctId":"NCT00404196","phase":"PHASE2","title":"LEO19123 Cream in the Treatment of Hand Eczema","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2006-10","conditions":"Hand Eczema","enrollment":75},{"nctId":"NCT00279162","phase":"PHASE3","title":"Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2005-12","conditions":"Psoriasis","enrollment":160},{"nctId":"NCT00216840","phase":"PHASE3","title":"Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2004-12","conditions":"Psoriasis of Scalp","enrollment":1350},{"nctId":"NCT02379793","phase":"PHASE1","title":"Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-03","conditions":"Skin and Connective Tissue Diseases","enrollment":33},{"nctId":"NCT03476746","phase":"PHASE1","title":"Dermatopharmacokinetic Trial of LEO 90100 Foam","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2018-03-20","conditions":"Healthy","enrollment":58},{"nctId":"NCT04227288","phase":"PHASE4","title":"A Study Evaluating the Efficacy and Tolerability of Enstilar Foam in Patients With Nail Psoriasis","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2021-11-01","conditions":"Nail Psoriasis","enrollment":6},{"nctId":"NCT03308799","phase":"PHASE3","title":"A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream","status":"COMPLETED","sponsor":"MC2 Therapeutics","startDate":"2017-10-03","conditions":"Psoriasis Vulgaris","enrollment":794},{"nctId":"NCT06685588","phase":"NA","title":"Efficacy of Topical 5-Fluorouracil Vs Calcipotriol As Photodynamic Therapy Pre-treatment for Field Actinic Keratoses","status":"NOT_YET_RECRUITING","sponsor":"St Vincent's University Hospital, Ireland","startDate":"2025-01","conditions":"Actinic Keratosis of Face and Scalp, Actinic Keratoses","enrollment":50},{"nctId":"NCT06333600","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss","status":"RECRUITING","sponsor":"Sohag University","startDate":"2023-05-20","conditions":"Dermatology, Female Pattern Baldness","enrollment":45},{"nctId":"NCT06327620","phase":"NA","title":"Treatment Of Oral Lichen Planus","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2022-01-15","conditions":"Lichen Planus","enrollment":15},{"nctId":"NCT06329258","phase":"PHASE4","title":"Combination of Sotyktu and Enstilar for Plaque Psoriasis","status":"COMPLETED","sponsor":"Psoriasis Treatment Center of Central New Jersey","startDate":"2022-12-06","conditions":"Psoriasis","enrollment":30},{"nctId":"NCT04220554","phase":"NA","title":"Improvement of Psoriasis Patients' Adherence to Topical Drugs","status":"COMPLETED","sponsor":"Odense University Hospital","startDate":"2020-06-19","conditions":"Psoriasis Vulgaris","enrollment":103},{"nctId":"NCT05954104","phase":"NA","title":"Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma","status":"COMPLETED","sponsor":"Egymedicalpedia","startDate":"2023-07-01","conditions":"Alopecia Areata","enrollment":80},{"nctId":"NCT05416320","phase":"EARLY_PHASE1","title":"Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2023-08","conditions":"Central Centrifugal Cicatricial Alopecia","enrollment":""},{"nctId":"NCT06011083","phase":"NA","title":"Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque Psoriasis","status":"COMPLETED","sponsor":"Assiut University","startDate":"2022-08-01","conditions":"Psoriasis Vulgaris, Fractional CO2 Laser","enrollment":40},{"nctId":"NCT03392311","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis","status":"COMPLETED","sponsor":"Guangdong Provincial Hospital of Traditional Chinese Medicine","startDate":"2019-07-23","conditions":"Mesenchymal Stromal Cells, Psoriasis, Drug Effect","enrollment":8},{"nctId":"NCT04275024","phase":"NA","title":"Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients","status":"COMPLETED","sponsor":"Guangdong Provincial Hospital of Traditional Chinese Medicine","startDate":"2020-04-01","conditions":"Mesenchymal Stromal Cells, Psoriasis, Drug Effect","enrollment":8},{"nctId":"NCT05957120","phase":"","title":"Subclinical Impairment of Cardiovascular System in Patients With Psoriasis","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2022-01-03","conditions":"Psoriasis, Inflammation, Endothelial Dysfunction","enrollment":100},{"nctId":"NCT04839731","phase":"EARLY_PHASE1","title":"Combination 5-FU / Calcipotriene Cream for SCCIS/SCC","status":"UNKNOWN","sponsor":"Carilion Clinic","startDate":"2021-04-14","conditions":"Squamous Cell Carcinoma","enrollment":30},{"nctId":"NCT04440371","phase":"NA","title":"Phototherapy Combination With Topicals in Vitiligo","status":"UNKNOWN","sponsor":"Jordan University of Science and Technology","startDate":"2020-06-21","conditions":"Vitiligo, Generalized","enrollment":40},{"nctId":"NCT05249972","phase":"PHASE3","title":"A Phase III Study in Subjects With Mild to Moderate Psoriasis.","status":"UNKNOWN","sponsor":"Lipidor AB","startDate":"2022-01-24","conditions":"Mild to Moderate Psoriasis","enrollment":294},{"nctId":"NCT05488990","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis","status":"COMPLETED","sponsor":"Lipidor AB","startDate":"2013-03-25","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT00437255","phase":"PHASE4","title":"Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-08","conditions":"Plaque Psoriasis","enrollment":122},{"nctId":"NCT05174598","phase":"PHASE3","title":"A Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis","status":"COMPLETED","sponsor":"Cadila Pharnmaceuticals","startDate":"2018-10-03","conditions":"Mild to Moderate Plaque Psoriasis","enrollment":278},{"nctId":"NCT04580537","phase":"PHASE2","title":"Assessing the Efficacy of Image-guided Laser-assisted Enstilar® Delivery for Treatment of Psoriatic Nails","status":"COMPLETED","sponsor":"Bispebjerg Hospital","startDate":"2020-10-02","conditions":"Nail Psoriasis","enrollment":11},{"nctId":"NCT00820950","phase":"PHASE2","title":"A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis","status":"COMPLETED","sponsor":"Incyte Corporation","startDate":"2007-05-31","conditions":"Psoriasis","enrollment":29},{"nctId":"NCT04994951","phase":"PHASE2","title":"Pilot Study of Traditional Chinese Medicine (Qing-Re-Liang-Xue Decoction) as Complementary Medicine for Psoriasis Vulgaris of Blood-heat Syndrome.","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Zhejiang Chinese Medical University","startDate":"2021-09","conditions":"Psoriasis Vulgaris","enrollment":200},{"nctId":"NCT04380597","phase":"","title":"Observational Study in Patients With Nail Psoriasis Treated With Enstilar® to Assess the Severity Change and the Quality of Life","status":"COMPLETED","sponsor":"Angeles Florez","startDate":"2019-03-26","conditions":"Nail Psoriasis","enrollment":10},{"nctId":"NCT02935582","phase":"","title":"PSOREAL - Managing PSOriasis in the REAL World","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2017-01","conditions":"Psoriasis Vulgaris","enrollment":1214},{"nctId":"NCT01268527","phase":"PHASE2","title":"A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"Eisai Limited","startDate":"2010-03-15","conditions":"Psoriasis Vulgaris","enrollment":30},{"nctId":"NCT03819218","phase":"PHASE2","title":"A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream in Adolescent Subjects","status":"TERMINATED","sponsor":"MC2 Therapeutics","startDate":"2018-12-27","conditions":"Psoriasis Vulgaris","enrollment":7},{"nctId":"NCT03506477","phase":"PHASE4","title":"Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2018-05-21","conditions":"Plaque Psoriasis, Psoriasis","enrollment":25},{"nctId":"NCT03802344","phase":"PHASE3","title":"This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream","status":"COMPLETED","sponsor":"MC2 Therapeutics","startDate":"2018-12-12","conditions":"Psoriasis Vulgaris","enrollment":498},{"nctId":"NCT03996252","phase":"EARLY_PHASE1","title":"Combination Topical Therapy for Treatment of Scalp Actinic Keratoses","status":"TERMINATED","sponsor":"Tulane University","startDate":"2019-07-01","conditions":"Actinic Keratoses","enrollment":15},{"nctId":"NCT04571151","phase":"PHASE4","title":"Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis","status":"UNKNOWN","sponsor":"Skin Sciences, PLLC","startDate":"2021-01","conditions":"Plaque Psoriasis","enrollment":30},{"nctId":"NCT04221906","phase":"PHASE1","title":"Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test","status":"COMPLETED","sponsor":"Boston Pharmaceuticals","startDate":"2020-01-06","conditions":"Chronic Plaque Psoriasis","enrollment":15},{"nctId":"NCT04555707","phase":"PHASE4","title":"The Maintenance Effect of Enstilar Foam in Combination With Otezla","status":"UNKNOWN","sponsor":"Derm Research, PLLC","startDate":"2020-06-24","conditions":"Psoriasis","enrollment":30}],"_emaApprovals":[],"_faersSignals":[{"count":341,"reaction":"PSORIASIS"},{"count":242,"reaction":"DRUG INEFFECTIVE"},{"count":127,"reaction":"PSORIATIC ARTHROPATHY"},{"count":126,"reaction":"PRURITUS"},{"count":108,"reaction":"MALAISE"},{"count":102,"reaction":"PAIN"},{"count":95,"reaction":"NAUSEA"},{"count":88,"reaction":"PNEUMONIA"},{"count":87,"reaction":"DIARRHOEA"},{"count":81,"reaction":"HYPERTENSION"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL4563773"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":1330,"therapeuticAreas":["Immunology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"calcipotriol","genericName":"calcipotriol","companyName":"NeoStrata Company, Inc.","companyId":"neostrata-company-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Calcipotriol is a synthetic derivative of calcitriol, a form of vitamin D, used in the treatment of psoriasis. It has been studied in clinical trials for various forms of psoriasis, including mild to moderate plaque psoriasis, chronic plaque psoriasis, and psoriasis vulgaris.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":15,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:22:29.596478+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}